Comparison

IL22 Antibody (Center) Blocking peptide

Item no. ABC-BP14032c
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Lyophilized
Specific against other
Citations Meng, S., et al. J Mol Cell Biol 2(4):223-230(2010)Thompson, C.L., et al. Cancer Causes Control 21(8):1165-1170(2010)Lafdil, F., et al. Cell. Mol. Immunol. 7(4):250-254(2010)Schuurhof, A., et al. Pediatr. Pulmonol. 45(6):608-613(2010)Davila, S., et al. Genes Immun. 11(3):232-238(2010)
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Interleukin-22,IL-22,Cytokine Zcyto18,IL-10-related T-cell-derived-inducible factor,IL-TIF,IL22,ILTIF,ZCYTO18
Similar products IL22, IL-22, ILTIF, ZCYTO18, Interleukin-22, Cytokine Zcyto18, IL-10-related T-cell-derived-inducible factor, IL-TIF
Available
Manufacturer - Category
Peptides; Blocking Peptides
Manufacturer - Targets
The synthetic peptide sequence used to generate the antibody AP14032c was selected from the Center region of IL22. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Bio Background
Cytokine that contributes to the inflammatory response in vivo.
Gene Name
IL22
Subtitle
Synthetic peptide
Formulation
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close